Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 184,847 | 165,797 | 98,417 | 99,134 | 84,390 |
| Marketable Securities | 75,370 | 239,183 | 224,332 | 386,857 | 294,426 |
| Receivables | N/A | N/A | N/A | N/A | 5,318 |
| Other current assets | 8,415 | 8,358 | 3,618 | 3,105 | 1,198 |
| TOTAL | $323,615 | $474,827 | $382,757 | $538,472 | $440,500 |
| Non-Current Assets | |||||
| PPE Net | 17,521 | 18,593 | 17,788 | 17,320 | 18,276 |
| Intangibles | 19,790 | 19,790 | 19,790 | 19,790 | 19,790 |
| Other Non-Current Assets | 48,197 | 37,205 | 38,611 | 39,525 | 31,957 |
| TOTAL | $85,508 | $75,588 | $76,189 | $76,635 | $70,023 |
| Total Assets | $409,123 | $550,415 | $458,946 | $615,107 | $510,523 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,491 | 19,628 | 19,142 | 18,029 | 19,744 |
| Accrued Expenses | 73,522 | 78,726 | 56,572 | 51,487 | 63,520 |
| Other current liabilities | 22,010 | 25,970 | 88,320 | 84,710 | 69,030 |
| TOTAL | $113,023 | $124,324 | $164,034 | $154,226 | $152,294 |
| Non-Current Liabilities | |||||
| Long Term Debt | 268,270 | 257,070 | N/A | 0 | N/A |
| Other Non-Current Liabilities | 44,990 | 34,434 | 35,417 | 37,445 | 42,223 |
| TOTAL | $313,260 | $291,504 | $35,417 | $37,445 | $42,223 |
| Total Liabilities | $426,283 | $415,828 | $199,451 | $191,671 | $194,517 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,855 | 105,788 | 102,113 | 102,055 | 101,122 |
| Common Shares | 1,743,740 | 1,743,109 | 1,689,346 | 1,656,702 | 1,381,699 |
| Retained earnings | -1,938,981 | -1,765,538 | -1,567,391 | -1,345,714 | -1,158,871 |
| Other shareholders' equity | 36 | -3 | 73 | 79 | 140 |
| TOTAL | $-17,160 | $134,587 | $259,495 | $423,436 | $316,006 |
| Total Liabilities And Equity | $409,123 | $550,415 | $458,946 | $615,107 | $510,523 |